Gemcitabine plus docetaxel administered every other week as first-line treatment of metastatic breast cancer: Preliminary results from a phase II trial

Cancer Statistics, 2002

2002 • 2,954 citations

Superior Survival With Capecitabine Plus Docetaxel Combination Therapy in Anthracycline-Pretreated Patients With Advanced Breast Cancer: Phase III Trial Results

2002 • 1,082 citations

A phase II study

2000 • 757 citations

Long-term follow-up of patients with complete remission following combination chemotherapy for metastatic breast cancer.

1996 • 754 citations

Salvage chemotherapy in anthracycline-pretreated metastatic breast cancer patients with docetaxel and gemcitabine: A multicenter phase II trial

1999 • 93 citations

Docetaxel and Gemcitabine in Anthracycline-Resistant Advanced Breast Cancer: A Hellenic Cooperative Oncology Group Phase II Study

2000 • 63 citations

Monthly docetaxel and weekly gemcitabine in metastatic breast cancer: A phase II trial

2001 • 53 citations

Evidence for in vivo synergism between docetaxel and gemcitabine in patients with metastatic breast cancer

2003 • 48 citations

Monotherapy options in the management of metastatic breast cancer

2003 • 46 citations

Treatment of advanced breast cancer with docetaxel and gemcitabine with and without human granulocyte colony-stimulating factor.

2002 • 45 citations

Monotherapy options in the management of metastatic breast cancer

2003 • 36 citations

Biweekly Docetaxel and Vinorelbine in Anthracycline-Resistant Metastatic Breast Cancer

2003 • 21 citations

Gemcitabine and targeted therapy in metastatic breast cancer

2002 • 21 citations

Gemcitabine and targeted therapy in metastatic breast cancer

2002 • 20 citations

Combination chemotherapy with docetaxel plus vinorelbine in metastatic breast cancer patients with prior exposure to anthracyclines

2001 • 17 citations

Vinorelbine and docetaxel as first-line chemotherapy in metastatic breast cancer

2003 • 16 citations

First line combination chemotherapy with docetaxel and vinorelbine in advanced breast cancer. A phase II study.

2002 • 9 citations